Academic Journal
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
| العنوان: | Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer |
|---|---|
| المؤلفون: | Hope S. Rugo, Sara M. Tolaney, Delphine Loirat, Kevin Punie, Aditya Bardia, Sara A. Hurvitz, Joyce O’Shaughnessy, Javier Cortés, Véronique Diéras, Lisa A. Carey, Luca Gianni, Martine J. Piccart, Sibylle Loibl, David M. Goldenberg, Quan Hong, Martin Olivo, Loretta M. Itri, Kevin Kalinsky |
| المصدر: | npj Breast Cancer, Vol 10, Iss 1, Pp 1-1 (2024) |
| بيانات النشر: | Nature Portfolio |
| سنة النشر: | 2024 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2374-4677 |
| Relation: | https://doi.org/10.1038/s41523-024-00650-6; https://doaj.org/toc/2374-4677; https://doaj.org/article/abb00ee86ac244e6959147aeb2f4a725 |
| DOI: | 10.1038/s41523-024-00650-6 |
| الاتاحة: | https://doi.org/10.1038/s41523-024-00650-6 https://doaj.org/article/abb00ee86ac244e6959147aeb2f4a725 |
| رقم الانضمام: | edsbas.8C6F0AE8 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 23744677 |
|---|---|
| DOI: | 10.1038/s41523-024-00650-6 |